Universal neonatal hearing screening before and during the COVID-19 pandemic.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 11 03 2023
revised: 12 07 2023
accepted: 20 07 2023
medline: 24 8 2023
pubmed: 11 8 2023
entrez: 10 8 2023
Statut: ppublish

Résumé

To verify the frequency of risk factors for hearing loss in newborns and their possible associations with universal neonatal hearing screening results before and during the COVID-19 pandemic. Historical cohort study with data analysis of newborns attended in a reference hearing health service of the Unified Health System (SUS) between January 2017 and December 2021. Those born in 2020 and 2021 were 91% less likely to fail the screening than those born in 2017, 2018, and 2019; therefore, they had a lower percentage of referrals for a retest. There was a decrease in congenital syphilis (1.00%), decrease in HIV (0.95%), and an increase in toxoplasmosis (0.58%) and increase in rubella cases in 2021 in relation to 2017. Syphilis had lower frequency rates during the COVID-19 pandemic (2020-2021). Newborns born in the pandemic year compared to those born pre-pandemic showed a reduction in the presence of two risk indicators for hearing loss and, consequently, a lower chance of failing the UNHS and a lower percentage of referral for retest.

Identifiants

pubmed: 37562319
pii: S0165-5876(23)00256-2
doi: 10.1016/j.ijporl.2023.111689
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111689

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Eduarda Besen (E)

Mastering Speech Therapy, Department of the Universidade Federal de Santa Catarina (UFSC), Florianópolis (SC), Brazil.

Karina Mary de Paiva (K)

Universidade Federal de Santa Catarina, Speech Therapy Department, Florianópolis (SC), Brazil.

Laura Faustino Gonçalves (LF)

Doctoral Student Speech Therapy at the Universidade de São Paulo (USP), São Paulo, Brazil.

Alessandra Gianella Samelli (AG)

Speech Therapy, Universidade de São Paulo (USP), São Paulo, Brazil.

Marcos José Machado (MJ)

Professor of the Pharmacy Course at the Federal University of Santa Catarina - UFSC, Department of Clinical Analysis, Brazil.

Anna Quialheiro Abreu da Silva (AQ)

Collective Health, Instituto Politécnico de Saúde do Norte (CESPU), Portugal.

Luciana Berwanger Cigana (LB)

Director of Instituto Otovida - Brazil, Florianópolis (SC), Brazil.

Carolina Schmitz Tiezerin (CS)

Mastering Speech Therapy, Department of the Universidade Federal de Santa Catarina (UFSC), Florianópolis (SC), Brazil.

Patrícia Haas (P)

Speech Therapy Department, Universidade Federal de Santa Catarina (UFSC), Florianópolis (SC), Brazil. Electronic address: patricia.haas@ufsc.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH